2-[3-(4-Pentylphenyl)Prop-2-Enoylamino]Benzoic Acid
CAS : 110683-10-8
Ref. 3D-FP158383
1g | Arrêté | ||
50mg | Arrêté | ||
100mg | Arrêté | ||
250mg | Arrêté | ||
500mg | Arrêté |
Informations sur le produit
- 2-[[1-Oxo-3-(4-pentylphenyl)-2-propen-1-yl]amino]-benzoic aicd
- 2-((1-Oxo-3-(4-pentylphenyl)-2-propenyl)amino)benzoic acid
- 2-[[1-Oxo-3-(4-pentylphenyl)-2-propen-1-yl]amino]benzoic acid
- 2-{[(2E)-3-(4-pentylphenyl)prop-2-enoyl]amino}benzoic acid
- 4-Acaa
- 4-Amylcinnamoylanthranilic acid
- Benzoic acid, 2-((1-oxo-3-(4-pentylphenyl)-2-propenyl)amino)-
- Benzoic acid, 2-[[1-oxo-3-(4-pentylphenyl)-2-propen-1-yl]amino]-
- N-(4-Pentylcinnamoyl)anthranilic acid
- N-(p-Amylcinnamoyl)anthranilic acid
- Voir d'autres synonymes
- p-Amylcinnamoylanthranilic acid
2-[3-(4-Pentylphenyl)Prop-2-Enoylamino]Benzoic Acid is a reactive, nonsteroidal anti-inflammatory drug that inhibits the production of adp-ribose. It acts by inhibiting intracellular calcium levels and stabilizing mitochondrial membrane potential. This drug has been shown to be neuroprotective in experimental models of oxidative injury and to have beneficial effects on postoperative pain. 2-[3-(4-Pentylphenyl)Prop-2-Enoylamino]Benzoic Acid has also been shown to reduce neuronal death and improve motor function in rats following spinal cord injury. This agent may act as a coadjuvant in combination therapy with other agents such as anthranilic acid or 2-aminoethoxydiphenyl borate.